Liquidia (LQDA) FCF Margin (2020 - 2026)

Liquidia's (LQDA) quarterly FCF Margin came in at 34.93% in Q1 2026, up 116643.0% year-on-year from N/an in Q1 2025, and down 27.43% quarter-over-quarter from 48.13% in Q4 2025.

Liquidia (LQDA) FCF Margin (2020 - 2026) Analysis & Trends

Liquidia's FCF Margin history runs 7 years deep, the most recent figure standing at 34.93% for Q1 2026.

  • On a quarterly basis, FCF Margin rose 116643.0% year-over-year to 34.93% in Q1 2026; TTM through Mar 2026 was 15.19%, a 74542.0% increase from a year earlier, with the FY2025 full-year figure at 23.96%, up 64503.0% from the prior year.
  • FCF Margin retreated to 34.93% in Q1 2026 per LQDA's latest filing, from 48.13% in the prior quarter.
  • Across five years, FCF Margin topped out at 48.13% in Q4 2025 and bottomed at 1131.51% in Q1 2025.
  • The 5-year median for FCF Margin is 280.01% (2022), against an average of 350.69%.
  • Across the five-year window, FCF Margin sank 66675 bps in 2024 and jumped 116643 bps in 2026, its largest moves.
  • Year by year, FCF Margin stood at 95.04% in 2022, then tumbled by 276 bps to 357.27% in 2023, then tumbled by 67 bps to 595.2% in 2024, then surged by 108 bps to 48.13% in 2025, then declined by 27 bps to 34.93% in 2026.
  • Per Business Quant, the three latest LQDA FCF Margin figures stand at 34.93% (Q1 2026), 48.13% (Q4 2025), and 19.66% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -5.22%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 12.86%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5.35%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 46.54%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 9.93%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 17.73%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.77%
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn 34.93%

Historic Data

Download Data
DateValue
Mar 31, 2026 34.93%
Dec 31, 2025 48.13%
Sep 30, 2025 -19.66%
Jun 30, 2025 -410.14%
Mar 31, 2025 -1,131.51%
Dec 31, 2024 -595.20%
Sep 30, 2024 -631.95%
Jun 30, 2024 -615.17%
Mar 31, 2024 -863.12%
Dec 31, 2023 -357.27%
Sep 30, 2023 -327.24%
Jun 30, 2023 -121.33%
Mar 31, 2023 -196.37%
Dec 31, 2022 -95.04%
Sep 30, 2022 -185.40%
Jun 30, 2022 -215.42%
Mar 31, 2022 -280.01%
Dec 31, 2021 -235.74%
Sep 30, 2021 -183.42%
Jun 30, 2021 -248.37%